Asker Healthcare Group AB (publ) (STO:ASKER)
Sweden
· Delayed Price · Currency is SEK 77.60
+5.60 (7.78%)
Apr 29, 2026, 9:50 AM CET
Asker Healthcare Group AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 16,787 | 15,025 | 13,453 | 11,718 | 9,354 |
| Revenue Growth (YoY) | 11.73% | 11.68% | 14.81% | 25.27% | - |
| Cost of Revenue | 9,916 | 9,147 | 8,934 | 7,936 | 6,741 |
| Gross Profit | 6,871 | 5,878 | 4,519 | 3,782 | 2,613 |
| Selling, General & Admin | 5,799 | 4,851 | 3,886 | 2,674 | 1,778 |
| Amortization of Goodwill & Intangibles | - | - | - | 167 | 68 |
| Other Operating Expenses | -21 | -15 | -7 | - | - |
| Operating Expenses | 5,778 | 4,836 | 3,879 | 3,069 | 2,008 |
| Operating Income | 1,093 | 1,042 | 640 | 713 | 605 |
| Interest Expense | -211 | -302 | -264 | -186 | -23 |
| Interest & Investment Income | 10 | 9 | 3 | 1 | 1 |
| Currency Exchange Gain (Loss) | -5 | -1 | 24 | 93 | -27 |
| Other Non Operating Income (Expenses) | -57 | -73 | -34 | -60 | -12 |
| EBT Excluding Unusual Items | 830 | 675 | 369 | 561 | 544 |
| Gain (Loss) on Sale of Assets | - | 32 | - | - | - |
| Other Unusual Items | -171 | -149 | -61 | - | - |
| Pretax Income | 659 | 558 | 308 | 561 | 544 |
| Income Tax Expense | 149 | 183 | 103 | 127 | 74 |
| Earnings From Continuing Operations | 510 | 375 | 205 | 434 | 470 |
| Minority Interest in Earnings | -18 | -15 | -2 | -4 | -3 |
| Net Income | 492 | 360 | 203 | 430 | 467 |
| Net Income to Common | 492 | 360 | 203 | 430 | 467 |
| Net Income Growth | 36.67% | 77.34% | -52.79% | -7.92% | - |
| Shares Outstanding (Basic) | 368 | 321 | 262 | 258 | 236 |
| Shares Outstanding (Diluted) | 368 | 321 | 262 | 258 | 236 |
| Shares Change (YoY) | 14.59% | 22.56% | 1.55% | 9.55% | - |
| EPS (Basic) | 1.34 | 1.12 | 0.77 | 1.67 | 1.98 |
| EPS (Diluted) | 1.34 | 1.12 | 0.77 | 1.67 | 1.98 |
| EPS Growth | 19.27% | 44.70% | -53.51% | -15.95% | - |
| Free Cash Flow | 738 | 879 | 901 | 853 | 258 |
| Free Cash Flow Per Share | 2.00 | 2.73 | 3.44 | 3.30 | 1.09 |
| Dividend Per Share | 0.390 | - | - | - | - |
| Gross Margin | 40.93% | 39.12% | 33.59% | 32.27% | 27.93% |
| Operating Margin | 6.51% | 6.93% | 4.76% | 6.08% | 6.47% |
| Profit Margin | 2.93% | 2.40% | 1.51% | 3.67% | 4.99% |
| Free Cash Flow Margin | 4.40% | 5.85% | 6.70% | 7.28% | 2.76% |
| EBITDA | 1,560 | 1,351 | 933 | 896 | 670 |
| EBITDA Margin | 9.29% | 8.99% | 6.93% | 7.65% | 7.16% |
| D&A For EBITDA | 467 | 309 | 293 | 183 | 65 |
| EBIT | 1,093 | 1,042 | 640 | 713 | 605 |
| EBIT Margin | 6.51% | 6.93% | 4.76% | 6.08% | 6.47% |
| Effective Tax Rate | 22.61% | 32.80% | 33.44% | 22.64% | 13.60% |
| Revenue as Reported | - | - | - | 11,751 | 9,378 |
Source: S&P Capital IQ. Standard template. Financial Sources.